US Stock MarketDetailed Quotes

AMGN Amgen

Watchlist

291.160
-3.430-1.16%

Close Feb 14 16:00 ET

291.250
+0.090+0.03%

Post 20:01 ET

156.41BMarket Cap38.51P/E (TTM)

Amgen Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

Total revenue

18.57%33.42B

10.86%9.09B

23.18%8.5B

20.07%8.39B

21.98%7.45B

7.09%28.19B

19.84%8.2B

3.77%6.9B

5.94%6.99B

-2.13%6.11B

Operating revenue

19.01%32.03B

11.27%8.72B

24.48%8.15B

20.32%8.04B

21.76%7.12B

8.50%26.91B

19.55%7.83B

4.99%6.55B

6.40%6.68B

2.01%5.85B

Cost of revenue

52.15%12.86B

0.00%3.11B

83.28%3.31B

78.49%3.24B

86.05%3.2B

31.92%8.45B

78.13%3.11B

13.73%1.81B

20.07%1.81B

10.19%1.72B

Gross profit

4.19%20.57B

17.51%5.97B

1.88%5.19B

-0.41%5.15B

-3.15%4.25B

-0.89%19.74B

-0.16%5.08B

0.65%5.1B

1.75%5.17B

-6.24%4.39B

Operating expense

12.38%13.31B

-3.93%3.66B

2.28%3.15B

30.29%3.24B

32.14%3.26B

14.40%11.84B

33.23%3.81B

27.95%3.08B

-14.41%2.49B

13.18%2.46B

Selling and administrative expenses

14.84%7.1B

-17.41%1.88B

20.10%1.63B

37.94%1.79B

43.72%1.81B

14.13%6.18B

44.66%2.27B

5.13%1.35B

-2.49%1.29B

2.44%1.26B

Research and development costs

24.67%5.96B

12.39%1.72B

34.38%1.45B

30.01%1.45B

26.94%1.34B

7.89%4.78B

15.86%1.53B

-2.97%1.08B

7.12%1.11B

10.32%1.06B

Other operating expenses

-71.79%248M

1,120.00%61M

-88.98%71M

-86.59%11M

-29.05%105M

74.75%879M

114.71%5M

12,780.00%644M

-84.87%82M

1,580.00%148M

Operating profit

-8.09%7.26B

81.83%2.31B

1.29%2.05B

-28.87%1.91B

-48.41%991M

-17.45%7.9B

-43.00%1.27B

-24.02%2.02B

23.35%2.68B

-23.16%1.92B

Net non-operating interest income expense

-9.74%-3.16B

9.01%-747M

-2.24%-776M

-7.45%-808M

-51.75%-824M

-104.48%-2.88B

-97.83%-821M

-106.25%-759M

-129.27%-752M

-84.07%-543M

Non-operating interest expense

9.74%3.16B

-9.01%747M

2.24%776M

7.45%808M

51.75%824M

104.48%2.88B

97.83%821M

106.25%759M

129.27%752M

84.07%543M

Other net income (expense)

-82.14%506M

-294.53%-782M

167.15%1.83B

3.46%-307M

-111.39%-235M

448.03%2.83B

700.00%402M

585.00%685M

-0.32%-318M

489.43%2.06B

Other non- operating income (expenses)

-82.14%506M

-294.53%-782M

167.15%1.83B

3.46%-307M

-111.39%-235M

448.03%2.83B

700.00%402M

585.00%685M

-0.32%-318M

489.43%2.06B

Income before tax

-41.32%4.61B

-8.22%782M

59.27%3.1B

-50.81%794M

-101.98%-68M

6.93%7.86B

-51.26%852M

-18.60%1.95B

5.42%1.61B

105.49%3.44B

Income tax

-54.39%519M

82.35%155M

24.88%271M

-79.57%48M

-92.51%45M

43.32%1.14B

-35.61%85M

-12.85%217M

9.81%235M

202.01%601M

Net income

-39.11%4.09B

-18.25%627M

63.58%2.83B

-45.90%746M

-103.98%-113M

2.52%6.72B

-52.54%767M

-19.27%1.73B

4.71%1.38B

92.48%2.84B

Net income continuous Operations

-39.11%4.09B

-18.25%627M

63.58%2.83B

-45.90%746M

-103.98%-113M

2.52%6.72B

-52.54%767M

-19.27%1.73B

4.71%1.38B

92.48%2.84B

Minority interest income

Net income attributable to the parent company

-39.11%4.09B

-18.25%627M

63.58%2.83B

-45.90%746M

-103.98%-113M

2.52%6.72B

-52.54%767M

-19.27%1.73B

4.71%1.38B

92.48%2.84B

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-39.11%4.09B

-18.25%627M

63.58%2.83B

-45.90%746M

-103.98%-113M

2.52%6.72B

-52.54%767M

-19.27%1.73B

4.71%1.38B

92.48%2.84B

Basic earnings per share

-39.33%7.62

-18.18%1.17

63.16%5.27

-46.12%1.39

-103.95%-0.21

3.12%12.56

-52.65%1.43

-19.45%3.23

4.88%2.58

97.77%5.32

Diluted earnings per share

-39.47%7.56

-18.31%1.16

62.11%5.22

-46.30%1.38

-103.98%-0.21

3.14%12.49

-52.67%1.42

-19.10%3.22

4.90%2.57

97.01%5.28

Dividend per share

5.63%9

5.63%2.25

9.79%8.52

9.79%2.13

Currency Unit

USD

Accounting Standards

US-GAAP

	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023
Total revenue	18.57%33.42B	10.86%9.09B	23.18%8.5B	20.07%8.39B	21.98%7.45B	7.09%28.19B	19.84%8.2B	3.77%6.9B	5.94%6.99B	-2.13%6.11B
Operating revenue	19.01%32.03B	11.27%8.72B	24.48%8.15B	20.32%8.04B	21.76%7.12B	8.50%26.91B	19.55%7.83B	4.99%6.55B	6.40%6.68B	2.01%5.85B
Cost of revenue	52.15%12.86B	0.00%3.11B	83.28%3.31B	78.49%3.24B	86.05%3.2B	31.92%8.45B	78.13%3.11B	13.73%1.81B	20.07%1.81B	10.19%1.72B
Gross profit	4.19%20.57B	17.51%5.97B	1.88%5.19B	-0.41%5.15B	-3.15%4.25B	-0.89%19.74B	-0.16%5.08B	0.65%5.1B	1.75%5.17B	-6.24%4.39B
Operating expense	12.38%13.31B	-3.93%3.66B	2.28%3.15B	30.29%3.24B	32.14%3.26B	14.40%11.84B	33.23%3.81B	27.95%3.08B	-14.41%2.49B	13.18%2.46B
Selling and administrative expenses	14.84%7.1B	-17.41%1.88B	20.10%1.63B	37.94%1.79B	43.72%1.81B	14.13%6.18B	44.66%2.27B	5.13%1.35B	-2.49%1.29B	2.44%1.26B
Research and development costs	24.67%5.96B	12.39%1.72B	34.38%1.45B	30.01%1.45B	26.94%1.34B	7.89%4.78B	15.86%1.53B	-2.97%1.08B	7.12%1.11B	10.32%1.06B
Other operating expenses	-71.79%248M	1,120.00%61M	-88.98%71M	-86.59%11M	-29.05%105M	74.75%879M	114.71%5M	12,780.00%644M	-84.87%82M	1,580.00%148M
Operating profit	-8.09%7.26B	81.83%2.31B	1.29%2.05B	-28.87%1.91B	-48.41%991M	-17.45%7.9B	-43.00%1.27B	-24.02%2.02B	23.35%2.68B	-23.16%1.92B
Net non-operating interest income expense	-9.74%-3.16B	9.01%-747M	-2.24%-776M	-7.45%-808M	-51.75%-824M	-104.48%-2.88B	-97.83%-821M	-106.25%-759M	-129.27%-752M	-84.07%-543M
Non-operating interest expense	9.74%3.16B	-9.01%747M	2.24%776M	7.45%808M	51.75%824M	104.48%2.88B	97.83%821M	106.25%759M	129.27%752M	84.07%543M
Other net income (expense)	-82.14%506M	-294.53%-782M	167.15%1.83B	3.46%-307M	-111.39%-235M	448.03%2.83B	700.00%402M	585.00%685M	-0.32%-318M	489.43%2.06B
Other non- operating income (expenses)	-82.14%506M	-294.53%-782M	167.15%1.83B	3.46%-307M	-111.39%-235M	448.03%2.83B	700.00%402M	585.00%685M	-0.32%-318M	489.43%2.06B
Income before tax	-41.32%4.61B	-8.22%782M	59.27%3.1B	-50.81%794M	-101.98%-68M	6.93%7.86B	-51.26%852M	-18.60%1.95B	5.42%1.61B	105.49%3.44B
Income tax	-54.39%519M	82.35%155M	24.88%271M	-79.57%48M	-92.51%45M	43.32%1.14B	-35.61%85M	-12.85%217M	9.81%235M	202.01%601M
Net income	-39.11%4.09B	-18.25%627M	63.58%2.83B	-45.90%746M	-103.98%-113M	2.52%6.72B	-52.54%767M	-19.27%1.73B	4.71%1.38B	92.48%2.84B
Net income continuous Operations	-39.11%4.09B	-18.25%627M	63.58%2.83B	-45.90%746M	-103.98%-113M	2.52%6.72B	-52.54%767M	-19.27%1.73B	4.71%1.38B	92.48%2.84B
Minority interest income
Net income attributable to the parent company	-39.11%4.09B	-18.25%627M	63.58%2.83B	-45.90%746M	-103.98%-113M	2.52%6.72B	-52.54%767M	-19.27%1.73B	4.71%1.38B	92.48%2.84B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-39.11%4.09B	-18.25%627M	63.58%2.83B	-45.90%746M	-103.98%-113M	2.52%6.72B	-52.54%767M	-19.27%1.73B	4.71%1.38B	92.48%2.84B
Basic earnings per share	-39.33%7.62	-18.18%1.17	63.16%5.27	-46.12%1.39	-103.95%-0.21	3.12%12.56	-52.65%1.43	-19.45%3.23	4.88%2.58	97.77%5.32
Diluted earnings per share	-39.47%7.56	-18.31%1.16	62.11%5.22	-46.30%1.38	-103.98%-0.21	3.14%12.49	-52.67%1.42	-19.10%3.22	4.90%2.57	97.01%5.28
Dividend per share	5.63%9	5.63%2.25	5.63%2.25	5.63%2.25	5.63%2.25	9.79%8.52	9.79%2.13	9.79%2.13	9.79%2.13	9.79%2.13
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

AMGN Amgen

Amgen Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Trending Stocks